139 related articles for article (PubMed ID: 23157547)
1. Interleukin-15 in gene therapy of cancer.
Ochoa MC; Mazzolini G; Hervas-Stubbs S; de Sanmamed MF; Berraondo P; Melero I
Curr Gene Ther; 2013 Feb; 13(1):15-30. PubMed ID: 23157547
[TBL] [Abstract][Full Text] [Related]
2. IL-15 can signal via IL-15Rα, JNK, and NF-κB to drive RANTES production by myeloid cells.
Chenoweth MJ; Mian MF; Barra NG; Alain T; Sonenberg N; Bramson J; Lichty BD; Richards CD; Ma A; Ashkar AA
J Immunol; 2012 May; 188(9):4149-57. PubMed ID: 22447977
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of tumor growth by NK1.1+ cells and CD8+ T cells activated by IL-15 through receptor beta/common gamma signaling in trans.
Rowley J; Monie A; Hung CF; Wu TC
J Immunol; 2008 Dec; 181(12):8237-47. PubMed ID: 19050240
[TBL] [Abstract][Full Text] [Related]
4. Cutting Edge: Differential Fine-Tuning of IL-2- and IL-15-Dependent Functions by Targeting Their Common IL-2/15Rβ/γc Receptor.
Meghnem D; Morisseau S; Frutoso M; Trillet K; Maillasson M; Barbieux I; Khaddage S; Leray I; Hildinger M; Quéméner A; Jacques Y; Mortier E
J Immunol; 2017 Jun; 198(12):4563-4568. PubMed ID: 28507024
[TBL] [Abstract][Full Text] [Related]
5. Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimera.
Votavova P; Tomala J; Kovar M
Immunol Lett; 2014; 159(1-2):1-10. PubMed ID: 24512738
[TBL] [Abstract][Full Text] [Related]
6. Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.
Van den Bergh J; Willemen Y; Lion E; Van Acker H; De Reu H; Anguille S; Goossens H; Berneman Z; Van Tendeloo V; Smits E
Oncotarget; 2015 Dec; 6(42):44123-33. PubMed ID: 26675759
[TBL] [Abstract][Full Text] [Related]
7. IL-15.IL-15Rα complex shedding following trans-presentation is essential for the survival of IL-15 responding NK and T cells.
Tamzalit F; Barbieux I; Plet A; Heim J; Nedellec S; Morisseau S; Jacques Y; Mortier E
Proc Natl Acad Sci U S A; 2014 Jun; 111(23):8565-70. PubMed ID: 24912180
[TBL] [Abstract][Full Text] [Related]
8. Adipocytes: A Novel Target for IL-15/IL-15Rα Cancer Gene Therapy.
Xiao R; Mansour AG; Huang W; Chrislip LA; Wilkins RK; Queen NJ; Youssef Y; Mao HC; Caligiuri MA; Cao L
Mol Ther; 2019 May; 27(5):922-932. PubMed ID: 30833178
[TBL] [Abstract][Full Text] [Related]
9. Different NK cell developmental events require different levels of IL-15 trans-presentation.
Lee GA; Liou YH; Wang SW; Ko KL; Jiang ST; Liao NS
J Immunol; 2011 Aug; 187(3):1212-21. PubMed ID: 21715685
[TBL] [Abstract][Full Text] [Related]
10. Development of IL-15/IL-15Rα sushi domain-IgG4 Fc complexes in Pichia pastoris with potent activities and prolonged half-lives.
Xu H; Shi M; Shao C; Li H; Wu J; Yu Y; Fang F; Guo Y; Xiao W
Microb Cell Fact; 2021 Jun; 20(1):115. PubMed ID: 34107983
[TBL] [Abstract][Full Text] [Related]
11.
Anton OM; Peterson ME; Hollander MJ; Dorward DW; Arora G; Traba J; Rajagopalan S; Snapp EL; Garcia KC; Waldmann TA; Long EO
Proc Natl Acad Sci U S A; 2020 Jan; 117(1):522-531. PubMed ID: 31871169
[TBL] [Abstract][Full Text] [Related]
12. IL-15R alpha-IgG1-Fc enhances IL-2 and IL-15 anti-tumor action through NK and CD8+ T cells proliferation and activation.
Wu Z; Xu Y
J Mol Cell Biol; 2010 Aug; 2(4):217-22. PubMed ID: 20671116
[TBL] [Abstract][Full Text] [Related]
13. IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation.
Mortier E; Woo T; Advincula R; Gozalo S; Ma A
J Exp Med; 2008 May; 205(5):1213-25. PubMed ID: 18458113
[TBL] [Abstract][Full Text] [Related]
14. Crystal Structure of the interleukin-15.interleukin-15 receptor alpha complex: insights into trans and cis presentation.
Olsen SK; Ota N; Kishishita S; Kukimoto-Niino M; Murayama K; Uchiyama H; Toyama M; Terada T; Shirouzu M; Kanagawa O; Yokoyama S
J Biol Chem; 2007 Dec; 282(51):37191-204. PubMed ID: 17947230
[TBL] [Abstract][Full Text] [Related]
15. Preassociation of IL-15 with IL-15R alpha-IgG1-Fc enhances its activity on proliferation of NK and CD8+/CD44high T cells and its antitumor action.
Dubois S; Patel HJ; Zhang M; Waldmann TA; Müller JR
J Immunol; 2008 Feb; 180(4):2099-106. PubMed ID: 18250415
[TBL] [Abstract][Full Text] [Related]
16. IL-15 Superagonist-Mediated Immunotoxicity: Role of NK Cells and IFN-γ.
Guo Y; Luan L; Rabacal W; Bohannon JK; Fensterheim BA; Hernandez A; Sherwood ER
J Immunol; 2015 Sep; 195(5):2353-64. PubMed ID: 26216888
[TBL] [Abstract][Full Text] [Related]
17. Characterization and favorable in vivo properties of heterodimeric soluble IL-15·IL-15Rα cytokine compared to IL-15 monomer.
Chertova E; Bergamaschi C; Chertov O; Sowder R; Bear J; Roser JD; Beach RK; Lifson JD; Felber BK; Pavlakis GN
J Biol Chem; 2013 Jun; 288(25):18093-103. PubMed ID: 23649624
[TBL] [Abstract][Full Text] [Related]
18. The exon-3-encoded domain of IL-15ralpha contributes to IL-15 high-affinity binding and is crucial for the IL-15 antagonistic effect of soluble IL-15Ralpha.
Bouchaud G; Garrigue-Antar L; Solé V; Quéméner A; Boublik Y; Mortier E; Perdreau H; Jacques Y; Plet A
J Mol Biol; 2008 Sep; 382(1):1-12. PubMed ID: 18656487
[TBL] [Abstract][Full Text] [Related]
19. Production of bioactive soluble interleukin-15 in complex with interleukin-15 receptor alpha from a conditionally-replicating oncolytic HSV-1.
Gaston DC; Odom CI; Li L; Markert JM; Roth JC; Cassady KA; Whitley RJ; Parker JN
PLoS One; 2013; 8(11):e81768. PubMed ID: 24312353
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and expression analysis of interleukin (IL)-15 and IL-15 receptor α from rock bream, Oplegnathus fasciatus.
Bae JS; Shim SH; Hwang SD; Kim JW; Park DW; Park CI
Fish Shellfish Immunol; 2013 Oct; 35(4):1209-15. PubMed ID: 23911652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
